STShinji Takashimizu

Shinji Takashimizu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shinji Takashimizu has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 June 2015
      • Vol. 50  (3) , 144-57

    The Influence of Drinking Based on Data from Health Check-up.

    by Seiichiro Kojima, Hiroyuki Ito, Shinji Takashimizu, Hajime Mizukami, Junko Nagata, Hitoshi Ichikawa, Takayuki Shirai, Koichi Shiraishi, Tetsuya Mine, Makoto Shiina, et al.

    A survey of 21,493 patients who visited our Health Check-up Center during the 6-year period from 2005 to 2010 was conducted for the endpoints of drinking situation and various lifestyle-related diseases. Males accounted for 57.2% (mean age: 53.2 ± 11.4) and females accounted for 42.8% (mean age: 52.5 ± 11.4) of patients surveyed. Patients with no drinking habit accounted for 24.8% and 62.9% of males and females, respectively, and a large gender difference was seen in drinking frequency. When examined by age group, drinking frequency was found to increase with age in males, but gradually decreased with age in females. An examination of alcohol consumption in males revealed that 23.5% had an ethanol conversion rate of 10 g/day, 19.1% had a rate of < 20 g/day, and 18.2% had a rate of < 40 g/day. Meanwhile, in females, 22.7% had a rate of ≤ 10 g/day, 7.6% had a rate of ≤ 20 g/day and 4.6% had a rate of ≤ 40 g/day. The association between lifestyle-related disease endpoints and alcohol consumption was next examined by multivariate logistic analysis. The association between drinking and body mass index (BMI) revealed an odds ratio of around 0.8 in patients who consumed ≤ 40 g/day and a significantly reduced frequency of obesity. The odds ratio of hypertension increased in a dose-dependent manner from 1.3 to 1.6 in patients who consumed ≥ 40 g/day. The frequency of high low-density lipoprotein cholesterol (LDL-C) was reduced in light drinkers and the odds ratio decreased from 0.77 to about 0.6 as alcohol consumption increased: The frequency of low high-density lipoprotein cholesterol (HDL-C) was similarly reduced in light drinkers, and the odds ratio decreased remarkably in a dose-dependent manner from 0.73 to 0.22 as alcohol consumption increased. The risk of triglycerides was reduced in light drinkers and was conversely significantly enhanced in heavy drinkers. In patients who consumed ≥ 20 g/day, the risk of impaired glucose tolerance increased significantly in a dose-dependent manner. Increased risk of hyperuricemia was seen even in light drinkers. and the odds ratio increased from 1.2 to 1.8 as alcohol consumption increased. The results of this cross-sectional study suggested that light drinking has a positive effect on BMI, LDL-C, HDL-C and triglycerides. On the other hand, heavy drinking was found to have a positive effect on LDL-C and HDL-C, but a negative effect on systolic blood pressure, triglycerides, fasting blood glucose and uric acid.

    • 1 April 2014
      • Vol. 49  (2) , 136-41

    [The outcome of patients with alcoholic liver cirrhosis].

    by Seiichiro Kojima, Hiroyuki Ito, Shinji Takashimizu, Hitoshi Ichikawa, Junko Nagata, Toshinori Yazaki, Hitoshi Imai, Takayuki Shirai, Norihito Watanabe

    We investigated the outcome of the patients with alcoholic liver cirrhosis who had visited our hospital from 2007 to 2013. We compared them with the patients with type C liver cirrhosis, matched in gender and in age. The patients with alcoholic liver cirrhosis who dropped out accounted for 19.3% (17 cases) of the whole. In 401 days of mean treatment period, the median value of the dropout patients was 43 days, indicating that a number of the patients dropped out in an early stage. The percentage of abstinence from alcoholic drinking was 35.3% in the dropout groups, whereas it was 67.6% in the non-dropout groups. It was conceivable that the abstinence was difficult for the dropout groups to perform. The percentage of the dropout in patients receiving livelihood protection was 35.7%, which was higher than that in general patients. There were no differences of the rate of dropout in general patients between alcoholic and type C liver cirrhosis. Since none of the patients with type C liver cirrhosis receiving livelihood protection dropped out, it was speculated that the cause of liver cirrhosis may be related to the rate of dropout. In summary, a number of patients with alcoholic liver cirrhosis have a difficulty in abstinence from alcoholic drinking. We also have to be careful to the high rate of dropout in patients with alcoholic liver cirrhosis receiving livelihood protection. In addition, it was thought that early incentive and education were important for these patients.


  • A case of diphyllobothrium nihonkaiense showed red spots on a mucous membrane of colon

    by Sachiko Arakawa, Toshinori Yazaki, Seiichiro Kojima, Takayuki Shirai, Maiko Kijima, Atsuko Maruno, Junko Nagata, Hitoshi Ichikawa, Shinji Takashimizu, Norihito Watanabe, et al.

  • Weight-based high- and low-dose ribavirin in combination with peginterferon α-2b therapy for genotype 2 chronic hepatitis C: A randomized trial

    by Tatehiro Kagawa, Sei-Ichiro Kojima, Koichi Shiraishi, Shinji Takashimizu, Naruhiko Nagata, Hirokazu Shiozawa, Yasuhiro Nishizaki, Akihiko Ikeda, Yoshihiro Tei, Kazuhiro Atsukawa, et al.


    • 20 July 2011
      • Vol. 36  (2) , 37-43

    Effect of endothelin A receptor antagonist on hepatic hemodynamics in cirrhotic rats. Implications for endothelin-1 in portal hypertension.

    by Shinji Takashimizu, Seiichiro Kojima, Yasuhiro Nishizaki, Tatehiro Kagawa, Koichi Shiraishi, Tetsuya Mine, Norihito Watanabe

    The effect of an endothelin (ET) A receptor antagonist on hepatic hemodynamics in cirrhotic rats was examined. Portal pressure and hepatic tissue blood flow in cirrhotic rats were measured. Plasma ET-1 levels were determined by radioimmunoassay. BQ-123 was infused to these rats at a rate of 10 nmol/min. The sinusoids were observed by scanning electron microscopy. The localization of ET-1 and ETA receptors was examined using the indirect immunoperoxidase method. In cirrhotic rats, the portal pressure significantly increased to 16.6 ± 1.5 cm H2O, and the hepatic tissue blood flow markedly decreased. Plasma ET-1 levels in cirrhotic rats were higher than those in normal rats. When BQ-123 was infused, the portal pressure was significantly reduced by more than 2 cm H2O, compared with the control group (p < 0.05). Hepatic tissue blood flow was maintained at the level before infusion. In liver cirrhosis, the sinusoids were covered with continuous endothelial cells, and the number of sinusoidal endothelial fenestrae extremely decreased. ET-1 was remarkably enhanced in sinusoidal endothelial cells within the regenerating nodules, and the reaction products of ETA receptors were mainly recognized in hepatic stellate cells. The augmented action of ET-1 via the ETA receptor may be involved in the mechanism of portal hypertension in liver cirrhosis.


    • 20 April 2011
      • Vol. 36  (1) , 8-12

    Good response chemotherapy for late-recurring gastric cancer in the gluteals, with peritoneal and retroperitoneal dissemination.

    by Toshiyuki Sakuma, Ryuzo Deguchi, Shinji Takashimizu, Fusao Ogasawara, Makoto Numata, Yasuo Ohtani, Shinkichi Sato, Tetsuya Mine, Yoshirou Iwata

    A 64-year-old woman presented with advanced gastric cancer (signet ring cell carcinoma) and underwent total gastrectomy in 1996. Postoperative recovery was good, and she was monitored regularly on an outpatient basis. Abdominal computed tomography in 1999 revealed a soft tissue shadow ventral to the origin of the celiac artery. Careful monitoring was continued on an outpatient basis. The patient began to experience gluteal swelling and pain in April 2008. Symptoms rapidly exacerbated and the patient was hospitalized for further examination. Gluteal muscle biopsy revealed signet ring cell carcinoma and bilateral hydronephrosis. Gluteal recurrence of the original gastric cancer was suggested, and systemic chemotherapy consisting of S-1 at 100 mg/day (3 weeks on, 1 week off) and CDDP (day 8) was started. Following the 6th cycle of chemotherapy, gluteal symptoms disappeared and the patient was judged to have achieved clinical complete response (CR). No adverse events or image findings suggesting new recurrence have since been identified. The patient received a total CDDP dose of 585 mg and clinical CR has been maintained as of 14 years after total gastrectomy and 18 months after recurrence.


    • 20 December 2009
      • Vol. 34  (4) , 156-63

    Endoscopic examination for duodenal ulcer bleeding during transcatheter arterial embolization: analysis of two cases.

    by Ryuzo Deguchi, Toshiyuki Sakuma, Fusao Ogasawara, Shinji Takashimizu, Jun Koike, Tetsuya Mine, Yoshiro Iwata

    Endoscopy is usually effective in treating duodenal ulcer bleeding, but depending on the lesion site and overall patient condition, hemostasis may be difficult to achieve with endoscopy alone. We described two patients with duodenal ulcer bleeding in whom endoscopic hemostasis was difficult. Immediately after transcatheter arterial embolization, endoscopic examination was used to confirm hemostasis and completing of the angiographic procedures.

  • Eight-week oral administration of meloxicam, a non-steroidal anti-inflammatory drug, prevents dose reduction of pegylated interferon α-2a in the treatment of chronic hepatitis C

    by Tatehiro Kagawa, Hirokazu Shiozawa, Sei-Ichiro Kojima, Shinji Takashimizu, Naruhiko Nagata, Makoto Numata, Fumitoshi Morino, Yasuhiro Nishizaki, Kaori Mochizuki, Norihito Watanabe, et al.

    Aim: We conducted a trial to evaluate whether eight‐week oral administration of meloxicam, a non‐steroidal anti‐inflammatory drug, would decrease the rate of the patients who required dose reduction of pegylated interferon α‐2a in the treatment of chronic hepatitis C. Methods: Sixty patients given weekly subcutaneous administration of pegylated interferon α‐2a at a dose of 180 μg for 48 weeks were allocated into the meloxicam group (n = 22) and the control group (n = 38) before interferon treatment. Meloxicam was given orally at a dose of 10 mg once a day for eight weeks from the start of interferon treatment. Results: The cumulative rate of dose‐reduction‐free patients was significantly higher in the meloxicam group (P < 0.05). Until week eight, 44.7% of the control group and 9.1% of the meloxicam group required dose reduction. Dose was modified by neutropenia in 31.6% and 18.2% of the control and meloxicam groups, respectively. Meloxicam relieved a declineof neutrophil count within the first eight weeks from 54.2% to 44.2% (P < 0.05). Multivariate analysis revealed that greater pretreatment neutrophil count and the use of meloxicam were independent factors associated with avoiding dose reduction. Sustained virological response was obtained in 52.6% of the patients. The multivariate logistic analysis revealed that viral serotype and viral load were the only independent factors associated with sustained virological response. Conclusion: Eight‐week administration of meloxicam prevented dose reduction of pegylated interferon by relieving a decline of neutrophil count in the treatment of chronic hepatitis C.


    • 20 July 2007
      • Vol. 32  (2) , 70-4

    Efficacy of balloon-occluded retrograde transvenous obliteration (B-RTO) performed in a patient with primary biliary cirrhosis with severe recurrent hepatic encephalopathy due to splenorenal shunt.

    by Shinji Takashimizu, Norihito Watanabe, Seiichiro Kojima, Tatehiro Kagawa, Tetsuya Mine, Kazunori Myojin, Jun Koizumi

    A 73 year old female had been diagnosed as primary biliary cirrhosis and Sjögren's syndrome since the age of 50. With persisting hyperammonemia, the patient was admitted on several occasions for the management of hepatic encephalopathy. Computed tomography (CT) scan and magnetic resonance imaging (MRI) of the abdomen showed varices in the splenic hilar region and a splenorenal shunt. A balloon-occluded retrograde transvenous obliteration (B-RTO) using 5% ethanolamine oleate plus iopamidol (EOI) was performed for treatment of recurrent hepatic encephalopathy. Celiac and superior mesenteric angiograms prior to B-RTO demonstrated a hepatofugal portal circulation through the splenic varices, splenorenal shunt, left renal vein and inferior vena cava. Immediately following the B-RTO, the portal circulation became restored to a hepatopetal blood flow and no visualization of the splenic varices and splenorenal shunt was verified. On day 2 post-B-RTO, blood NH3 level was noted to have decreased from 134 to 61 μg/dL, indicating an improvement of hyperammonemia. The liver parenchymal blood flow using the dynamic CT time-concentration curve showed a decrease in hepatic artery blood flow and a marked increase in portal flow following the B-RTO. The patient has since been free from any signs of hepatic encephalopathy due to hyperammonemia for over 5 years following the B-RTO. B-RTO may be considered useful for the treatment of severe recurrent hepatic encephalopathy due to the collateral shunt in portal hypertension.


    • 20 March 2007
      • Vol. 32  (1) , 34-41

    Altered cell motility behaviour and reorganization of contractile proteins after primary monolayer cultures of isolated hepatocytes.

    by Norihito Watanabe, Shinji Takashimizu, Seiichiro Kojima, Tatehiro Kagawa, Yasuhiro Nishizaki, Tetsuya Mine

    The aim of this study is to elucidate the temporal changes of the cell motility and the localization of contractile proteins in isolated hepatocytes after primary monolayer cultures. Cultured hepatocyte couplets and triplets were observed at 4 hr and 24 hr with time-lapse video recording using video-enhanced contrast, differential interference contact (VEC-DIC) microscopy. The distribution of actin and myosin was examined by immunofluorescence, transmission electron microscopy, and electron microscopy using a whole cell mount. In 4 hr-cultured hepatocyte couplets, bile canalicular contractions, mediated by the surrounding actin and myosin, were spontaneous and forceful. At 24 hr, the cells spread and flattened out, and VECDIC microscopy revealed rope-like fibers, possibly stress fibers in the flattened cytoplasm. Stress fiber motilities were active and independent of other cell movements. The saltatory movement of the vesicles in the cytoplasm was clearly visualized with time-lapse recording. However, the bile canaliculi between two hepatocytes were closed at 24 hr, and the canalicular contractions were no longer seen. Actin and myosin were found in the same area as stress fibers were observed by VEC-DIC microscopy. It was possible to visualize high-resolution images of the dynamic cell function in the living hepatocytes, using VEC-DIC microscopy with time-lapse recording. The changes in the cell motility pattern may be ascribed to the reorganization of the contractile proteins in isolated hepatocytes after monolayer cultures. Four hr-cultured hepatocyte couplets are considered to be similar to the liver in a living state in terms of the cell morphology and the physiological motility function of the canaliculi.